ClinicalTrials.gg

Program

avoralstat

Also written as “BCX4161”.

Its studies are mostly in Angioedemas, Hereditary · Macular Edema, led by BioCryst Pharmaceuticals.

Furthest: phase 3, since Nov 24, 20146 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
BioCryst Pharmaceuticals60 open or runningphase 3since Nov 24, 2014Nov 5, 2013none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 5, 2013First study: phase 2 study in Angioedemas, HereditaryFirst studyNCT01984788 · 24 enrolled · Germany, United Kingdom
  2. Apr 24, 2014Phase 1 study in Angioedemas, HereditaryNCT02125162 · 28 enrolled · United Kingdom
  3. Aug 14, 2014Phase 1 study in Angioedemas, HereditaryNCT02218294 · 7 enrolled · United Kingdom
  4. Nov 24, 2014Phase 3 study in Angioedemas, HereditaryNCT02303626 · 110 enrolled · United States, Belgium, Canada and more
  5. Jan 20, 2016Phase 3 study in Angioedemas, HereditaryNCT02670720 · 6 enrolled · Belgium, France
  6. Sep 26, 2025Phase 1 study in Diabetic Macular Edema (DME)NCT07228559 · 3 enrolled · United States, Australia

TargetBeta

KLKB1 →read by rule
“Plasma kallikrein inhibitor”ChEMBL 37, by rule

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07228559Diabetic Macular Edema (DME) · United States, Australia1TerminatedApr 17, 20263
NCT02670720Angioedemas, Hereditary · Belgium, France3TerminatedFeb 20166
NCT02303626Angioedemas, Hereditary · United States, Belgium, Canada and more3CompletedJan 2016110
NCT02218294Angioedemas, Hereditary · United Kingdom1CompletedSep 20147
NCT02125162Angioedemas, Hereditary · United Kingdom1CompletedJul 201428
NCT01984788Angioedemas, Hereditary · Germany, United Kingdom2CompletedMay 201424

How it is read

Names in the registry

  • “BCX4161”, 4 entries
  • “avoralstat”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.